These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36983232)

  • 21. Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.
    Maciorkowska M; Musiałowska D; Małyszko J
    Adv Clin Exp Med; 2019 Nov; 28(11):1571-1575. PubMed ID: 31756066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients.
    Kanda E; Suzuki A; Makino M; Tsubota H; Kanemata S; Shirakawa K; Yajima T
    Sci Rep; 2022 Nov; 12(1):20012. PubMed ID: 36411366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.
    Kadowaki T; Komuro I; Morita N; Akiyama H; Kidani Y; Yajima T
    Diabetes Ther; 2022 Feb; 13(2):275-286. PubMed ID: 35006534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.
    Zhang Y; Wang J; Ren Y; Yan WF; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Jan; 20(1):11. PubMed ID: 33413395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China.
    Li H; Wang Q; Ke J; Lin W; Luo Y; Yao J; Zhang W; Zhang L; Duan S; Dong Z; Chen X
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Adropin as a Potential Marker Predicting Obesity and Obesity-associated Cancer in Korean Patients With Type 2 Diabetes Mellitus.
    Choi HN; Yim JE
    J Cancer Prev; 2018 Dec; 23(4):191-196. PubMed ID: 30671402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus.
    Andrade-Sierra J; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Díaz-de la Cruz EN; García-Sánchez A; Cardona-Muñoz EG; Munguía-Galaviz FJ; de Alba-Razo A; Miranda-Díaz AG
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adropin and Irisin in Patients with Cardiac Cachexia.
    Kalkan AK; Cakmak HA; Erturk M; Kalkan KE; Uzun F; Tasbulak O; Diker VO; Aydin S; Celik A
    Arq Bras Cardiol; 2018 Jul; 111(1):39-47. PubMed ID: 29972412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
    Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W
    Front Public Health; 2022; 10():1047794. PubMed ID: 36420005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
    Wu J; Liu D; Yang L; Liu J
    Med Sci Monit; 2022 Jun; 28():e936323. PubMed ID: 35684937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes.
    Duan S; Zhou M; Lu F; Chen C; Chen S; Geng L; Zhang C; Guo H; Zeng M; Sun B; Mao H; Zhang B; Xing C; Yuan Y
    Endocrine; 2023 Jul; 81(1):77-89. PubMed ID: 37004636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
    Usman MS; Siddiqi TJ; Anker SD; Bakris GL; Bhatt DL; Filippatos G; Fonarow GC; Greene SJ; Januzzi JL; Khan MS; Kosiborod MN; McGuire DK; Piña IL; Rosenstock J; Vaduganathan M; Verma S; Zieroth S; Butler J
    J Am Coll Cardiol; 2023 Jun; 81(25):2377-2387. PubMed ID: 37344038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Wu YH; Wang SY; Li MX; He H; Yin WJ; Guo YH; Zhang HQ; Sun ZM; Zhang D; Wang X; Sun SY; Tang SX; Du R; Zhang CH
    Diabetes Metab Syndr Obes; 2020; 13():99-105. PubMed ID: 32021356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
    Kaewput W; Thongprayoon C; Chewcharat A; Rangsin R; Satirapoj B; Kaewput C; Suwannahitatorn P; Bathini T; Mao MA; Cato LD; Harrison AM; Vaitla P; Cheungpasitporn W
    Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Adropin Levels in Patients on Hemodialysis.
    Boric-Skaro D; Mizdrak M; Luketin M; Martinovic D; Tokic D; Vilovic M; Supe-Domic D; Kurir TT; Bozic J
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33920330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of chronic kidney disease among type 2 diabetes mellitus patients in central South Africa.
    Mhundwa W; Joubert G; Mofokeng TR
    S Afr Fam Pract (2004); 2023 May; 65(1):e1-e6. PubMed ID: 37265141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of adropin as a preliminary test to exclude acute pulmonary embolism: a prospective study.
    Orun S; Celikkol A; Basol BI; Yeniay E
    BMC Pulm Med; 2022 Sep; 22(1):351. PubMed ID: 36115957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating adropin levels in patients with endometrium cancer.
    Nergiz S; Altinkaya SO; Kurt Ömürlü İ; Yuksel H; Küçük M; Demircan Sezer S
    Gynecol Endocrinol; 2015; 31(9):730-5. PubMed ID: 26172926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.